异动解读 | 德康医疗夜盘大涨6.60%,季度业绩超预期

异动解读
02 May

周四夜盘,德康医疗(DXCM)股价大涨6.60%,引起市场广泛关注。这一显著涨幅主要源于公司公布的强劲第一季度业绩以及对全年业绩的乐观展望。

根据公司最新发布的财报,德康医疗第一季度销售额达到10.4亿美元,同比增长12%,超出分析师预期的10.2亿美元。公司调整后每股收益为0.32美元,高于预期的0.33美元。这一亮眼业绩主要得益于糖尿病患者对其连续血糖监测仪(CGMs)的强劲需求。

除了优异的季度表现,德康医疗还重申了46.0亿美元的年度收入预期,进一步提振了投资者信心。公司最近推出的创新产品,如面向非胰岛素使用者的首款非处方CGM设备Stelo,以及获得美国食品和药物管理局批准的更新版G7 15天CGM,都有望为公司未来增长提供动力。这些积极因素共同推动了德康医疗股价在夜盘交易中的强劲上涨。

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10